Lung Cancer expanded expanded
FDA Approves Alectinib for ALK-Positive Non-Small Cell Lung Cancer
NCI, January 19, 2016
(Time Posted: Jan-21-2016 10AM)
NCI, January 19, 2016
(Time Posted: Jan-21-2016 10AM)
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Barlesi Fabrice et al. Lancet (London, England) 2016 Jan
(Time Posted: Jan-20-2016 11AM)
Barlesi Fabrice et al. Lancet (London, England) 2016 Jan
(Time Posted: Jan-20-2016 11AM)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Cheng Donavan T et al. The Journal of molecular diagnostics : JMD 2015 May 17(3) 251-64
(Time Posted: Jan-20-2016 11AM)
Cheng Donavan T et al. The Journal of molecular diagnostics : JMD 2015 May 17(3) 251-64
(Time Posted: Jan-20-2016 11AM)
More information on this topic
No hay comentarios:
Publicar un comentario